Skip to main content

stock

CAI · Caris Life Sciences, Inc.

What Caris Life Sciences, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live CAI price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on CAI.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Services-Medical Laboratories (SIC 8071)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
282,595,186 as of 2026-08-03 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
15.5%
Net
10.6%

Returns

ROE
17.8%
ROA
8.6%

Health

Current ratio
5.5x
Debt/equity
0.7x

Deep value

NCAV
$419.94M
NCAV per share
$1.49
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$263.71M—Gross profit: unreported by this company.$26.93M-$637,000
10-Q filed 2026-08-05
2026-03-31$216.17M—Gross profit: unreported by this company.$5.28M-$510,000
10-Q filed 2026-05-08
2025-12-31$292.89M—Gross profit: unreported by this company.$88.41M$81.96M
10-K filed 2026-03-03
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$216.83M—Gross profit: unreported by this company.$32.64M$24.32M
10-Q filed 2025-11-05
2025-06-30$181.40M—Gross profit: unreported by this company.-$17.99M-$71.79M
10-Q filed 2026-08-05
2025-03-31$120.92M—Gross profit: unreported by this company.-$57.95M-$102.58M
10-Q filed 2026-05-08
2024-09-30$101.62M—Gross profit: unreported by this company.-$60.84M-$67.73M
10-Q filed 2025-11-05
2024-06-30$100.05M—Gross profit: unreported by this company.-$67.01M-$66.19M
10-Q filed 2025-08-12
Assets
$1.23B
Equity
$591.73M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$812.03M$45.11M-$68.09M$66.89M
2024-12-31$412.26M-$257.12M-$281.89M-$253.64M
2023-12-31$306.13M-$319.55M-$341.42M-$298.42M

Company filings

events

  • Regulation FD disclosure

    Regulation FD disclosure
    Sep 148-K
  • Results

    Results
    Aug 58-K
  • Shareholder vote results

    Shareholder vote results
    Jun 58-K
  • Results

    Results
    May 78-K
  • Material agreement, Agreement ended, New debt

    Material agreementAgreement endedNew debt
    Apr 28-K
  • Results, Regulation FD disclosure

    ResultsRegulation FD disclosure
    Feb 268-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

All funds

News

Stories that named CAI, and the market events around them.

Sign in to see this

Board

The CAI board could not be loaded.

Retry the CAI board

nakagai

Signals on CAI come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the CAI board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Caris Life Sciences, Inc. (CAI): SEC filings, financials and insider trades · Nakagai